National Health Determination under paragraph 98C(1)(b) Amendment 2017 (No. 1) (PB 3 of 2017) (Cth)

PB 3 of 2017

National Health Determination under paragraph 98C(1)(b) Amendment 2017
(No. 1)

_____________________________________________________________________

I, LOUISE CLARKE, First Assistant Secretary (Acting), Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health and Aged Care, make this Instrument under paragraph 98C(1)(b) of the National Health Act 1953.

Dated 17 JANUARY 2017

LOUISE CLARKE

First Assistant Secretary (Acting)

Pharmaceutical Benefits Division

Department of Health

1              Name of Instrument

(1)This Instrument is the National Health Determination under paragraph 98C(1)(b) Amendment 2017 (No. 1).

(2)This Instrument may also be cited as PB 3 of 2017.

2              Commencement  

This instrument commences on 1 February 2017.

3              Amendments to Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008)

Schedule 1 amends the Determination under paragraph 98C(1)(b) of the National Health Act 1953 (PB 119 of 2008).

Schedule 1            Amendments

1. Schedule 3, entry for Alprazolam

omit:

Tablet 2 mg

1. Schedule 4, entry for Glyceryl Trinitrate

insert as first item in the column headed “Form (strength, type, size, etc.)”:

Tablets 300 micrograms, 100